<SEC-DOCUMENT>0001867096-26-000023-index.html : 20260423
<SEC-HEADER>0001867096-26-000023.hdr.sgml : 20260423
<ACCEPTANCE-DATETIME>20260423170912
ACCESSION NUMBER:		0001867096-26-000023
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260423
DATE AS OF CHANGE:		20260423
EFFECTIVENESS DATE:		20260423

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Xeris Biopharma Holdings, Inc.
		CENTRAL INDEX KEY:			0001867096
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				871082097
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40880
		FILM NUMBER:		26889631

	BUSINESS ADDRESS:	
		STREET 1:		1375 WEST FULTON STREET, SUITE 1300
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60607
		BUSINESS PHONE:		844-445-5704

	MAIL ADDRESS:	
		STREET 1:		1375 WEST FULTON STREET, SUITE 1300
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60607
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>xers2025annualreport.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: xers2025annualreport.pdf

</DOCUMENT>
</SEC-DOCUMENT>